startup

Dust BioSolutions

Dust BioSolutions is a start-up company focusing on industrial applications of biotechnology.
  • Life Science & Healthcare
  • Startup Stage
  • Manufacturing
  • B2B
  • 2011
  • 1-10 Employees
  • Not found
  • Martinsried, DE
  • dustbiosolutions.com
  • Dust BioSolutions GmbH
  • Bayern

Profile is not claimed et

This profile is created by the Startbase Analyst Team. If you are a team member of this company you can claim the profile in order to make changes to it.

Is this your company? Claim profile

About the company

Dust BioSolutions has developed proprietary technologies based upon microbiologically induced calcite precipitation. It is a bio-geochemical process that induces calcium carbonate precipitation within the soil matrix. Biomineralization in the form of calcium carbonate precipitation has naturally evolved and can be traced back millions of years. Soil microorganisms that are natural components of ecological systems are the key driver in carbonate precipitation. The microorganisms precipitate calcium carbonate, serve as nucleation site and achieve a tridimensional solidification of particles. We have developed a process that is robust to changing environmental conditions, such as varying temperatures and pH levels, and that can be applied on different soil types.

Dust BioSolutions Funding

News about Dust BioSolutions

Recent mentions of Dust BioSolutions in podcasts & videos:

Jobs at Dust BioSolutions:

Other Startups nearby

GNA Biosolutions
Startup 2010 Martinsried
GNA Biosolutions
Developing instruments, OEM modules and tests for the ultrafast, molecular biological detection of a wide range of pathogens. The core is a specially developed technology called laser PCR.
Eisbach
Startup 2019 Planegg-Martinsried
Eisbach
Development of drugs targeting chromatin regulatory mechanisms important for tumors.
ChromoTek
Startup 2008 Martinsried
ChromoTek
Development and commercialization of Nanobody-based reagents.
Lindis Biotech
Startup 2010 Planegg
Lindis Biotech
Development of Triomab® antibodies - a new class of T-cell activating bispecific antibodies that enable the immune system to transform malignant cancers into treatable and potentially curable diseases.
Bind-X
Startup 2013 Planegg
Bind-X
Industrial applications in the field of biotechnology.

FYI: English edition available

Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?

Go to English edition

FYI: Deutsche Edition verfügbar

Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?

Deutsche Edition öffnen